A Prospective Study of Microalbuminuria and Incident Coronary Heart Disease and Its Prognostic Significance in a British Population: The EPIC-Norfolk Study

American Journal of Epidemiology

Volumn 159, Issue 3, 2004, Pages 284-293

  Yuyun, Matthew F ^a   Khaw, Kay Tee ^a   Luben, Robert ^a   Welch, Ailsa ^a   Bingham, Sheila ^b   Day, Nicholas E ^a   Wareham, Nicholas J ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Albuminuria; Cardiovascular diseases; Coronary disease; Diabetes mellitus; Hypertension; Proteinuria; Risk factors

Indexed keywords

CARDIOVASCULAR DISEASE;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; MULTIVARIATE ANALYSIS; POPULATION RISK; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED KINGDOM;

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; CORONARY DISEASE; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0942301317     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh037     Document Type: Article

References (44)

1. Rayner M, Petersen S. European cardiovascular disease statistics. British Heart Foundation Health Promotion Research Group. Oxford, United Kingdom: Department of Public Health, University of Oxford, 2000.
2. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet, 2000;355:675-87.
3. Deckert T, Yokoyama H, Mathiesen E, et al. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ 1996;312:871-4.
4. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 1997;157:1413-18.
5. Bigazzi R, Bianchi S, Baldari D, et al. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential, hypertension. J Hypertens 1998;16:1325-33.
6. Jensen JS, Feldt Rasmussen B, Strandgaard S, et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000;35:898-903.
7. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey. Lancet 1988;2:530-3.
8. Jensen JS, Borch Johnsen K, Feldt Rasmussen B, et al. Urinary albumin excretion and history of acute myocardial infarction in a cross-sectional population study of 2,613 individuals. J Cardiovasc Risk 1997;4:121-5.
9. Damsgaard EM, Froland A, Jorgensen OD, et al. Microalbuminuria as predictor of increased mortality in elderly people. BMJ 1990;300:297-300.
10. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-6.
11. Jager A, Kostense PJ, Ruhe HG, et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999;19:617-24.
12. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:1777-82.
13. Borch Johnsen K, Feldt Rasmussen B, Strandgaard S, et al. Urinary albumin excretion: an independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999;19:1992-7.
14. Kuusisto J, Mykkanen L, Pyorala K, et al. Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation 1995;91:831-7.
15. Gorgels WJ, van der Graaf Y, Hjemdahl P, et al. Urinary excretions of high molecular weight beta-thromboglobulin and albumin are independently associated with coronary heart disease in women: a nested case-control study of middle-aged women in the Diagnostisch Onderzoek Mammacarcinoom (DOM) Cohort, Utrecht, Netherlands. Am J Epidemiol 1995;142:1157-64.
16. Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999;80(suppl 1):95-103.
17. Rose G. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962;27:645-58.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
19. Stamp RJ. Measurement of albumin in urine by-end-point immunonephelometry. Ann Clin Biochem 1988;25:442-3.
20. Heinegard D, Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta 1973;43:305-10.
21. Ahn CW, Song YD, Kim JH, et al. The validity of random urine specimen albumin measurement as a screening test for diabetic nephropathy. Yonsei Med J 1999;40:40-5.
22. Ginsberg JM, Chang BS, Matarese RA, et al. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 1983;309:1543-6.
23. Nathan DM, Rosenbaum C, Protasowicki VD. Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 1987;10:414-18.
24. Wiegmann TB, Chonko AM, Barnard MJ, et al. Comparison of albumin excretion rate obtained with different times of collection. Diabetes Care 1990;13:864-71.
25. Zelmanovitz T, Gross JL, Oliveira JR, et al. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 1997;20:516-19.
26. Mogensen CE, Keane WF, Bennett PH, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995;346:1080-4.
27. Berton G, Cordiano R, Palmieri R, et al: Microalbuminuria during acute myocardial infarction: a strong predictor for 1-year mortality. Eur Heart J 2001;22:1466-75.
28. Mogensen CE, Vestbo E, Poulsen PL, et al. Microalbuminuria and potential confounders: a review and some observations on variability of urinary albumin excretion. Diabetes Care 1995;18:572-81.
29. Schultz CJ, Dalton RN, Turner C, et al. Freezing method affects the concentration and variability of urine proteins and the interpretation of data on microalbuminuria. The Oxford Regional Prospective Study Group. Diabet Med 2000;17:7-14.
30. Collins AC, Sethi M, MacDonald FA, et al. Storage temperature and differing methods of sample preparation in the measurement of urinary albumin. Diabetologia 1993;36:993-7.
31. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993;16:642-52.
32. Connell SJ, Hollis S, Tieszen KL, et al. Gender and the clinical usefulness of the albumin:creatinine ratio. Diabet Med 1994;11:32-6.
33. Kesteloot H, Joossens JV. On the determinants of the creatinine clearance: a population study. J Hum Hypertens 1996;10:245-9.
34. Vora JP, Ibrahim HA, Bakris GL. Responding to the challenge of diabetic nephropathy: the historic evolution of detection, prevention and management. J Hum Hypertens 2000;14:667-85.
35. American Diabetes Association Clinical Practice Recommendations 2001. Diabetes Care 2001;24(suppl 1):S1-133.
36. Mogensen CE, Cahchati A, Christensen CK, et al. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985-86;9:85-95.
37. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
38. HOPE Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE Study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000;355:253-9.
39. Jensen JS. Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:1324-9.
40. Winocour PH, Harland JO, Millar JP, et al. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 1992;93:71-81.
41. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
42. Thomsen TF, Davidsen M, Ibsen H, et al. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials: PRECARD and the Copenhagen Risk Score. J Cardiovasc Risk 2001;8:291-7.
43. Yudkin JS, Chaturvedi N. Developing risk stratification charts for diabetic and nondiabetic subjects. Diabet Med 1999;16:219-27.
44. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93.